37501395	O	O
FULL	O	O
RESULT	O	O
:	O	O
Examination	O	O
:	O	O
Chest	O	O
CT	O	O
with	O	O
contrast	O	O
,	O	O
06/05/2008	O	O
Clinical	O	O
History	O	O
:	O	O
Breast	O	O
cancer	O	O
,	O	O
follow	O	O
up	O	O
pulmonary	O	O
nodules	O	O
.	O	O
Comparison	O	O
:	O	O
12/17/2007	O	O
.	O	O
Findings	O	O
:	O	O
Spiral	O	O
CT	O	O
of	O	O
the	O	O
chest	O	O
was	O	O
performed	O	O
with	O	O
2.5-mm	O	O
collimation	O	O
using	O	O
intravenous	O	O
contrast	O	O
.	O	O
The	O	O
cardiac	O	O
chamber	O	O
sizes	O	O
are	O	O
normal	O	O
.	O	O
Coronary	3_Yellow_Days	O
artery	3_Yellow_Days	O
calcifications	3_Yellow_Days	O
are	3_Yellow_Days	O
present	3_Yellow_Days	O
.	O	O
Tiny	3_Yellow_Days	O
pericardial	3_Yellow_Days	O
effusion	3_Yellow_Days	O
.	O	O
Adenopathy	3_Yellow_Days	O
at	3_Yellow_Days	O
the	3_Yellow_Days	O
right	3_Yellow_Days	O
hilum	3_Yellow_Days	O
and	3_Yellow_Days	O
ill-defined	3_Yellow_Days	O
right	3_Yellow_Days	O
and	3_Yellow_Days	O
left	3_Yellow_Days	O
paratracheal	3_Yellow_Days	O
lymph	3_Yellow_Days	O
nodes	3_Yellow_Days	O
are	3_Yellow_Days	O
unchanged	3_Yellow_Days	O
.	O	O
There	O	O
are	O	O
a	O	O
number	O	3_Yellow_Days
of	O	3_Yellow_Days
scattered	3_Yellow_Days	3_Yellow_Days
small	3_Yellow_Days	3_Yellow_Days
pulmonary	3_Yellow_Days	3_Yellow_Days
nodules	3_Yellow_Days	3_Yellow_Days
in	3_Yellow_Days	3_Yellow_Days
the	3_Yellow_Days	3_Yellow_Days
1-3-mm	3_Yellow_Days	3_Yellow_Days
range	3_Yellow_Days	3_Yellow_Days
of	3_Yellow_Days	3_Yellow_Days
size	3_Yellow_Days	3_Yellow_Days
in	3_Yellow_Days	3_Yellow_Days
both	3_Yellow_Days	3_Yellow_Days
lungs	3_Yellow_Days	3_Yellow_Days
.	O	O
There	O	O
is	O	O
a	O	O
little	O	3_Yellow_Days
lesser	O	1_Red_Minutes
degree	O	1_Red_Minutes
of	O	1_Red_Minutes
inspiration	O	1_Red_Minutes
with	O	1_Red_Minutes
increased	O	1_Red_Minutes
attenuation	O	1_Red_Minutes
of	O	1_Red_Minutes
lung	O	O
bases	O	O
with	O	O
some	O	O
minimal	O	O
dependent	O	O
atelectasis	O	O
.	O	O
No	O	O
effusion	O	O
.	O	O
Low	O	O
attenuation	O	O
hepatic	O	O
lesions	O	O
are	O	O
presumably	O	O
simple	O	O
cysts	O	O
.	O	O
Cholecystectomy	O	O
clips	O	O
and	O	O
nephrectomy	O	O
clips	O	O
on	O	O
the	O	O
right	O	O
.	O	O
The	O	O
remainder	O	O
of	O	O
the	O	O
visualized	O	O
upper	O	O
abdomen	O	O
is	O	O
unremarkable	O	O
.	O	O
IMPRESSION	O	O
:	O	O
Adenopathy	3_Yellow_Days	3_Yellow_Days
and	3_Yellow_Days	3_Yellow_Days
tiny	3_Yellow_Days	3_Yellow_Days
pulmonary	3_Yellow_Days	3_Yellow_Days
nodules	3_Yellow_Days	3_Yellow_Days
remain	3_Yellow_Days	3_Yellow_Days
unchanged	3_Yellow_Days	3_Yellow_Days
and	3_Yellow_Days	O
nonspecific	3_Yellow_Days	O
over	3_Yellow_Days	O
almost	3_Yellow_Days	O
a	3_Yellow_Days	O
year	3_Yellow_Days	3_Yellow_Days
now	3_Yellow_Days	O
.	O	O
Active	3_Yellow_Days	O
metastatic	3_Yellow_Days	O
disease	3_Yellow_Days	O
is	3_Yellow_Days	O
unlikely	3_Yellow_Days	O
.	O	O
They	3_Yellow_Days	O
may	3_Yellow_Days	3_Yellow_Days
be	3_Yellow_Days	3_Yellow_Days
followed	3_Yellow_Days	3_Yellow_Days
up	3_Yellow_Days	3_Yellow_Days
to	3_Yellow_Days	3_Yellow_Days
document	3_Yellow_Days	3_Yellow_Days
long	3_Yellow_Days	3_Yellow_Days
term	3_Yellow_Days	3_Yellow_Days
stability	3_Yellow_Days	3_Yellow_Days
.	O	O
CT	O	O
CT	O	O
,	O	O
LUNG	O	O
,	O	O
MED	O	O
,	O	O
PLEURA	O	O
W/CONTRAST	O	O
38698927	O	O
FULL	O	O
RESULT	O	O
:	O	O
Examination	O	O
:	O	O
CT	O	O
of	O	O
the	O	O
chest	O	O
with	O	O
intravenous	O	O
contrast	O	O
,	O	O
05/14/2009	O	O
.	O	O
Clinical	O	O
History	O	O
:	O	O
Nasopharyngeal	O	O
rhabdomyosarcoma	O	O
.	O	O
Comparison	O	O
:	O	O
The	O	O
study	O	O
was	O	O
correlated	O	O
with	O	O
the	O	O
previous	O	O
12/11/2008	O	O
.	O	O
Findings	O	O
:	O	O
Bilateral	3_Yellow_Days	3_Yellow_Days
nonspecific	3_Yellow_Days	3_Yellow_Days
pulmonary	3_Yellow_Days	3_Yellow_Days
nodules	3_Yellow_Days	3_Yellow_Days
remain	O	3_Yellow_Days
in	O	3_Yellow_Days
view	O	3_Yellow_Days
of	O	3_Yellow_Days
stability	O	3_Yellow_Days
may	3_Yellow_Days	3_Yellow_Days
be	3_Yellow_Days	3_Yellow_Days
due	3_Yellow_Days	3_Yellow_Days
to	3_Yellow_Days	3_Yellow_Days
noncalcified	3_Yellow_Days	3_Yellow_Days
granuloma	3_Yellow_Days	3_Yellow_Days
though	3_Yellow_Days	3_Yellow_Days
followup	3_Yellow_Days	3_Yellow_Days
to	3_Yellow_Days	3_Yellow_Days
exclude	3_Yellow_Days	3_Yellow_Days
metastatic	3_Yellow_Days	3_Yellow_Days
disease	3_Yellow_Days	3_Yellow_Days
is	3_Yellow_Days	3_Yellow_Days
recommended	3_Yellow_Days	3_Yellow_Days
.	O	O
No	O	O
new	O	O
nodules	O	O
are	O	O
noted	O	O
.	O	O
Lesions	O	O
are	O	O
noted	O	O
in	O	O
the	O	O
left	O	O
lung	O	O
image	O	O
38	O	O
,	O	O
43	O	O
,	O	O
56	O	O
,	O	O
58	O	O
,	O	O
in	O	O
the	O	O
lingula	O	O
,	O	O
peripherally	O	O
image	O	O
73	O	O
,	O	O
and	O	O
in	O	3_Yellow_Days
the	O	3_Yellow_Days
right	O	3_Yellow_Days
lung	O	3_Yellow_Days
nodules	O	3_Yellow_Days
are	O	3_Yellow_Days
noted	O	3_Yellow_Days
posteriorly	O	3_Yellow_Days
in	O	3_Yellow_Days
the	O	3_Yellow_Days
right	O	3_Yellow_Days
lower	O	3_Yellow_Days
lobe	O	3_Yellow_Days
,	O	O
image	O	O
58	O	O
and	O	O
along	O	O
the	O	O
minor	O	O
fissure	O	O
,	O	O
image	O	O
65	O	O
,	O	O
and	O	O
image	O	O
67	O	O
.	O	O
No	O	O
sign	O	O
of	O	O
consolidation	O	O
to	O	O
suggest	O	O
pneumonia	O	O
.	O	O
There	O	O
are	O	O
no	O	O
pleural	O	O
effusions	O	O
.	O	O
Limited	O	O
imaging	O	O
of	O	O
the	O	O
abdomen	O	O
shows	O	O
no	O	O
focal	O	O
liver	O	O
lesions	O	O
.	O	O
A	O	O
hypodensity	O	O
in	O	O
the	O	O
spleen	O	O
was	O	O
present	O	O
on	O	O
the	O	O
previous	O	O
study	O	O
is	O	O
incompletely	O	O
imaged	O	O
on	O	O
our	O	O
study	O	O
,	O	O
most	O	O
likely	O	O
a	O	O
cyst	O	O
or	O	O
hemangioma	O	O
.	O	O
Followup	O	O
can	O	O
be	O	O
performed	O	O
.	O	O
The	O	O
adrenal	O	O
glands	O	O
are	O	O
unremarkable	O	O
.	O	O
There	O	O
are	O	O
bilateral	O	3_Yellow_Days
central	O	3_Yellow_Days
lines	O	3_Yellow_Days
.	O	O
The	O	O
right-sided	O	O
central	O	O
line	O	O
terminates	O	O
over	O	O
the	O	O
region	O	O
of	O	O
the	O	O
SVC	O	O
as	O	O
does	O	O
the	O	O
left-sided	O	O
central	O	O
line	O	O
.	O	O
No	O	O
mediastinal	O	O
,	O	O
hilar	O	O
or	O	O
axillary	O	O
adenopathy	O	O
.	O	O
IMPRESSION	O	O
:	O	O
No	O	O
definite	O	O
sign	O	O
of	O	O
metastatic	O	O
disease	O	O
.	O	O
Stable	3_Yellow_Days	3_Yellow_Days
nonspecific	3_Yellow_Days	3_Yellow_Days
pulmonary	3_Yellow_Days	3_Yellow_Days
nodules	3_Yellow_Days	3_Yellow_Days
are	O	3_Yellow_Days
unchanged	O	3_Yellow_Days
from	O	3_Yellow_Days
the	O	3_Yellow_Days
interval	O	3_Yellow_Days
from	O	3_Yellow_Days
the	O	3_Yellow_Days
previous	O	3_Yellow_Days
study	O	3_Yellow_Days
up	3_Yellow_Days	3_Yellow_Days
to	3_Yellow_Days	3_Yellow_Days
3	3_Yellow_Days	3_Yellow_Days
mm	3_Yellow_Days	3_Yellow_Days
in	3_Yellow_Days	3_Yellow_Days
diameter	3_Yellow_Days	3_Yellow_Days
.	O	O
Continued	3_Yellow_Days	3_Yellow_Days
followup	3_Yellow_Days	3_Yellow_Days
to	3_Yellow_Days	3_Yellow_Days
exclude	3_Yellow_Days	3_Yellow_Days
growth	3_Yellow_Days	O
can	3_Yellow_Days	O
be	3_Yellow_Days	O
performed	3_Yellow_Days	O
.	O	O
No	O	O
new	O	O
nodules	O	O
are	O	O
noted	O	O
.	O	O
CT	O	O
CT	O	O
,	O	O
LUNG	O	O
,	O	O
MED	O	O
,	O	O
PLEURA	O	O
W/CONTRAST	O	O
71260	O	O
CT	O	O
CHEST	O	O
w	O	O
CT05/07/2007	O	O
/	O	O
EXAM_CODES	O	O
>	O	O
<	O	O
REPOEnhanced	O	O
chest	O	O
CT	O	O
with	O	O
additional	O	O
thin	O	O
section	O	O
reconstructed	O	O
images	O	O
is	O	O
compared	O	O
to	O	O
CT	O	O
of	O	O
3-26-07	O	O
.	O	O
No	3_Yellow_Days	O
significant	3_Yellow_Days	O
change	3_Yellow_Days	O
in	3_Yellow_Days	O
the	3_Yellow_Days	O
mild	3_Yellow_Days	3_Yellow_Days
mediastinal	3_Yellow_Days	3_Yellow_Days
and	3_Yellow_Days	3_Yellow_Days
mild	3_Yellow_Days	3_Yellow_Days
right	3_Yellow_Days	3_Yellow_Days
hilar	3_Yellow_Days	3_Yellow_Days
adenopathy	3_Yellow_Days	3_Yellow_Days
.	O	O
A	3_Yellow_Days	O
small	3_Yellow_Days	3_Yellow_Days
nodule	3_Yellow_Days	3_Yellow_Days
in	3_Yellow_Days	3_Yellow_Days
the	3_Yellow_Days	3_Yellow_Days
left	3_Yellow_Days	3_Yellow_Days
base	3_Yellow_Days	3_Yellow_Days
posteriorly	3_Yellow_Days	3_Yellow_Days
-LRB-	3_Yellow_Days	O
series	3_Yellow_Days	O
2	3_Yellow_Days	O
,	3_Yellow_Days	O
image	3_Yellow_Days	O
42	3_Yellow_Days	O
-RRB-	3_Yellow_Days	O
has	3_Yellow_Days	O
enlargedslightly	3_Yellow_Days	O
.	O	O
Numerous	3_Yellow_Days	3_Yellow_Days
other	3_Yellow_Days	3_Yellow_Days
very	3_Yellow_Days	3_Yellow_Days
small	3_Yellow_Days	3_Yellow_Days
bilateral	3_Yellow_Days	3_Yellow_Days
pulmonary	3_Yellow_Days	3_Yellow_Days
nodules	3_Yellow_Days	3_Yellow_Days
have	3_Yellow_Days	3_Yellow_Days
not	3_Yellow_Days	3_Yellow_Days
changed	3_Yellow_Days	3_Yellow_Days
appreciably	3_Yellow_Days	O
.	O	O
No	O	O
definite	O	O
new	O	O
nodules	O	O
.	O	O
Radiation	O	O
fibrosis	O	1_Red_Minutes
with	O	1_Red_Minutes
volume	O	3_Yellow_Days
loss	O	3_Yellow_Days
in	O	3_Yellow_Days
the	O	3_Yellow_Days
right	O	3_Yellow_Days
midlung	O	3_Yellow_Days
anteriorly	O	3_Yellow_Days
.	O	O
Stable	O	3_Yellow_Days
scattered	O	3_Yellow_Days
scarring	O	O
in	O	O
the	O	O
bases	O	O
.	O	O
Scattered	3_Yellow_Days	3_Yellow_Days
skeletal	3_Yellow_Days	3_Yellow_Days
metastases	3_Yellow_Days	3_Yellow_Days
,	3_Yellow_Days	O
a	3_Yellow_Days	O
few	3_Yellow_Days	O
of	3_Yellow_Days	O
which	3_Yellow_Days	O
are	3_Yellow_Days	O
slightly	3_Yellow_Days	O
more	3_Yellow_Days	O
prominent	3_Yellow_Days	O
.	O	O
Healing	3_Yellow_Days	O
pathologic	3_Yellow_Days	O
fractures	3_Yellow_Days	O
of	3_Yellow_Days	O
the	3_Yellow_Days	O
posterolateral	3_Yellow_Days	O
left	3_Yellow_Days	O
8th	3_Yellow_Days	O
and	3_Yellow_Days	O
9th	3_Yellow_Days	O
ribs	3_Yellow_Days	O
,	O	O
with	O	O
slightly	O	O
more	O	O
callus	O	O
formation	O	O
today	O	O
.	O	O
Mild	O	3_Yellow_Days
heterogeneous	O	3_Yellow_Days
enlargement	O	3_Yellow_Days
of	O	3_Yellow_Days
the	O	3_Yellow_Days
both	O	3_Yellow_Days
lobes	O	3_Yellow_Days
of	O	3_Yellow_Days
the	O	3_Yellow_Days
thyroid	O	3_Yellow_Days
gland	O	3_Yellow_Days
,	O	O
unchanged	O	3_Yellow_Days
.	O	O
Right	O	O
mastectomy	O	O
.	O	O
Small	O	O
esophageal	O	O
hiatal	O	O
hernia	O	O
.	O	O
Cholelithiasis	O	O
.	O	O
Stable	3_Yellow_Days	O
left	3_Yellow_Days	O
renal	3_Yellow_Days	O
calculus	3_Yellow_Days	O
.	O	O
37695890	O	O
FULL	O	O
RESULT	O	O
:	O	O
Examination	O	O
:	O	O
CT	O	O
Chest	O	O
,	O	O
07/21/2008	O	O
.	O	O
Clinical	O	O
History	O	O
:	O	O
Sarcoidosis	O	O
,	O	O
followup	O	O
.	O	O
Findings	O	O
:	O	O
CT	O	O
chest	O	O
7/12/2007	O	O
and	O	O
02/19/2008	O	O
.	O	O
Numerous	3_Yellow_Days	O
subcentimeter	3_Yellow_Days	O
nodules	3_Yellow_Days	O
,	3_Yellow_Days	O
in	3_Yellow_Days	O
parenchymal	3_Yellow_Days	O
or	3_Yellow_Days	O
subpleural	3_Yellow_Days	O
locations	3_Yellow_Days	O
,	3_Yellow_Days	O
and	3_Yellow_Days	O
spiculated	3_Yellow_Days	O
masses	3_Yellow_Days	O
,	3_Yellow_Days	O
like	3_Yellow_Days	O
a	3_Yellow_Days	O
band	3_Yellow_Days	O
of	3_Yellow_Days	O
fibrosis	3_Yellow_Days	O
,	3_Yellow_Days	O
are	3_Yellow_Days	O
noted	3_Yellow_Days	O
in	3_Yellow_Days	O
the	3_Yellow_Days	O
lungs	3_Yellow_Days	O
bilaterally	3_Yellow_Days	O
.	O	O
The	3_Yellow_Days	O
pre-existing	3_Yellow_Days	O
disease	3_Yellow_Days	O
has	3_Yellow_Days	O
been	3_Yellow_Days	O
relatively	3_Yellow_Days	3_Yellow_Days
stable	3_Yellow_Days	3_Yellow_Days
.	O	O
Additionally	O	O
,	O	O
there	O	O
is	O	O
a	O	O
localized	1_Red_Minutes	3_Yellow_Days
area	1_Red_Minutes	3_Yellow_Days
of	1_Red_Minutes	3_Yellow_Days
new	1_Red_Minutes	3_Yellow_Days
ground-glass	1_Red_Minutes	3_Yellow_Days
opacities	1_Red_Minutes	3_Yellow_Days
in	1_Red_Minutes	3_Yellow_Days
the	1_Red_Minutes	3_Yellow_Days
right	1_Red_Minutes	3_Yellow_Days
base	1_Red_Minutes	3_Yellow_Days
-LRB-	O	O
image	O	O
#	O	O
71	O	O
to	O	O
77	O	O
-RRB-	O	O
.	O	O
This	O	O
is	O	O
associated	O	O
with	O	O
peribronchial	O	3_Yellow_Days
thickening	O	3_Yellow_Days
and	O	O
nodules	O	O
.	O	O
This	1_Red_Minutes	O
could	1_Red_Minutes	O
represent	1_Red_Minutes	O
superimposed	1_Red_Minutes	3_Yellow_Days
infectious	1_Red_Minutes	3_Yellow_Days
process	1_Red_Minutes	3_Yellow_Days
.	O	O
However	O	O
,	O	O
the	O	O
progressing	1_Red_Minutes	O
sarcoidosis	1_Red_Minutes	O
is	1_Red_Minutes	O
probably	1_Red_Minutes	O
more	1_Red_Minutes	3_Yellow_Days
likely	1_Red_Minutes	3_Yellow_Days
.	O	O
Clinical	1_Red_Minutes	3_Yellow_Days
correlation	1_Red_Minutes	3_Yellow_Days
is	1_Red_Minutes	3_Yellow_Days
recommended	1_Red_Minutes	3_Yellow_Days
.	O	O
Additionally	O	O
,	O	O
there	O	O
are	O	O
multiple	3_Yellow_Days	3_Yellow_Days
enlarged	3_Yellow_Days	3_Yellow_Days
lymph	3_Yellow_Days	3_Yellow_Days
nodes	3_Yellow_Days	3_Yellow_Days
in	3_Yellow_Days	O
the	3_Yellow_Days	O
mediastinum	3_Yellow_Days	O
predominantly	O	O
at	O	O
the	O	O
prevascular	O	O
chain	O	O
,	O	O
right	O	O
paratracheal	O	O
chain	O	O
and	O	O
subcarinal	O	3_Yellow_Days
chains	O	3_Yellow_Days
as	O	O
well	O	O
as	O	O
in	O	O
the	O	O
hila	O	O
bilaterally	O	O
,	O	O
grossly	3_Yellow_Days	O
unchanged	3_Yellow_Days	O
.	O	O
There	O	O
is	O	O
no	O	O
evidence	O	O
of	O	O
new	O	O
lymph	O	O
node	O	O
or	O	O
lymphadenopathy	O	O
.	O	O
The	O	O
visualized	O	O
soft	O	O
tissue	O	O
is	O	O
unremarkable	O	O
.	O	O
IMPRESSION	O	O
:	O	O
Development	3_Yellow_Days	O
of	3_Yellow_Days	3_Yellow_Days
localized	3_Yellow_Days	3_Yellow_Days
area	3_Yellow_Days	3_Yellow_Days
of	3_Yellow_Days	3_Yellow_Days
ground-glass	3_Yellow_Days	3_Yellow_Days
opacities	3_Yellow_Days	3_Yellow_Days
in	3_Yellow_Days	3_Yellow_Days
the	3_Yellow_Days	3_Yellow_Days
right	3_Yellow_Days	3_Yellow_Days
lower	3_Yellow_Days	3_Yellow_Days
lobe	3_Yellow_Days	3_Yellow_Days
and	3_Yellow_Days	3_Yellow_Days
relatively	3_Yellow_Days	3_Yellow_Days
stable	3_Yellow_Days	3_Yellow_Days
disease	3_Yellow_Days	3_Yellow_Days
in	3_Yellow_Days	3_Yellow_Days
the	3_Yellow_Days	3_Yellow_Days
rest	3_Yellow_Days	3_Yellow_Days
of	3_Yellow_Days	3_Yellow_Days
the	3_Yellow_Days	3_Yellow_Days
lungs	3_Yellow_Days	3_Yellow_Days
,	3_Yellow_Days	O
mediastinum	3_Yellow_Days	O
,	3_Yellow_Days	O
and	3_Yellow_Days	O
hila	3_Yellow_Days	O
.	O	O
CT	O	O
CT	O	O
,	O	O
LUNG	O	O
,	O	O
MED	O	O
,	O	O
PLEURA	O	O
W/CONTRAST	O	O

